Business Insights
Diagnostic Technologies
Diseases
Point-of-Care Testing
Research & Development
Sign In
Autoimmune
Cancer
Cardiovascular
COVID-19
Health Topics
Infectious
Diseases
AnchorDx enrolling U.S. clinical trial for bladder cancer assay
The study, which will enroll more than 1,000 participants, aims to evaluate the noninvasive, qPCR assay which detects two DNA methylation biomarkers in urine specimens from patients suspected of having bladder cancer.
November 23, 2022
Biological Dynamics embarks on clinical utility studies for pancreatic cancer detection assay
Biological Dynamics said that it is collaborating with Qure Healthcare and Curta to also evaluate the effects of its pancreatic cancer detection assay on patient outcomes and healthcare economics.
November 23, 2022
FDA grants EUA for Lucira Health’s COVID-19 and flu combination test
Lucira Health has received FDA emergency use authorization (EUA) for its test to detect and differentiate COVID-19 and both strains of influenza.
November 23, 2022
Low-value prostate cancer screening has Medicare spending ramifications, study finds
The consequences of low-value PSA cancer screening could amount to more than $275 million in spending for Medicare, according to the authors' estimates.
November 22, 2022
‘Good’ cholesterol worse for some adults: NIH study
In the study, lower levels of "good" cholesterol were associated with increased risks for heart attacks for white but not Black adults.
November 23, 2022
Meridian Bioscience Q4 revenues drop 14% on lower COVID-19 testing, misses analysts' estimates
Diagnostics segment revenue growth was driven by nonmolecular assay products, which increased 22%.
November 22, 2022
Most Popular
DNA forensic evidence frees Ohio man of rape, attempted rape
Low-value prostate cancer screening has Medicare spending ramifications, study finds
‘Good’ cholesterol worse for some adults: NIH study
Empatica receives FDA clearance for digital biomarker platform, closes Series B financing
PerkinElmer launches adeno-associated virus vector detection kits for research
Widespread HbA1c screening enables earlier type 2 diabetes diagnosis in U.K. study
Biocare Medical acquires Empire Genomics to expand molecular biomarker portfolio
The acquisition of Empire Genomics will expand Biocare Medical’s molecular biomarker portfolio substantially.
November 22, 2022
Qiagen adds monkeypox test to automated PCR platform
Addressing a need to improve surveillance of monkeypox, Qiagen announced that it has launched a research-use-only monkeypox test strip capable of detecting both variants of the virus.
November 22, 2022
Sense Biodetection inks deal for distribution of COVID-19 testing platform in the Netherlands, Belgium, Luxembourg
Sense Biodetection has signed a distribution deal with R-Biopharm Nederland, bringing its instrument-free platform for COVID-19 testing to the Benelux Union.
November 22, 2022
Widespread HbA1c screening enables earlier type 2 diabetes diagnosis in U.K. study
HbA1c screening in adults between 40 and 70 years of age can reduce the time to diabetes diagnosis by a median of 2.2 years compared with routine clinical care, the authors found.
November 22, 2022
NIH website enables anonymous reporting of at-home COVID-19 test results
COVID-19 test results provide valuable data that public health departments can use to assess the needs and modify the responses in the local community, the state, or the nation, NIH noted.
November 22, 2022
Johns Hopkins cell-free DNA blood test detects 80% of liver cancers in study
The researchers believe there is potential to leverage the technology to develop a commercial blood test to detect hepatocellular cancer with higher accuracy than current tests.
November 18, 2022
Page 1 of 222
Next Page
